Literature DB >> 16933092

Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing.

Ramprakash Govindarajan1, Andrey Zinchuk, Bruno Hancock, Evgenyi Shalaev, Raj Suryanarayanan.   

Abstract

PURPOSE: Evaluation of the effect of formulation composition and processing variables on the microenvironment in solid dosage forms, based on ionization of indicator probes.
MATERIALS AND METHODS: Sulfonephthalein indicators were intimately mixed with individual excipients, binary excipient mixtures or multi-component blends by the solvent deposition method. Diffuse reflectance visible spectroscopy of these solids provided a measure of indicator ionization extent. Indicator solution studies yielded equations relating solution pH to the ratio of the absorbance signals of the ionized to that of the unionized form, for each indicator. These equations and the spectral data of the indicator-treated solids were used to calculate an acidity function, 'pH(eq)' for the solids. The ionization of incorporated probes was also monitored during various stages of simulated pharmaceutical processing viz. wet and dry mixing.
RESULTS: The pH(eq) provided a measure of the physicochemical environment experienced by the probe in the solid. The surface nature of formulation components and their surface area available for interaction influenced the overall properties of the final blend. The extent of probe ionization varied at different stages of a simulated wet mixing-drying process. The pH of the excipient suspension was not a good predictor of the probe ionization in the final dried solid. Indicator ionization is expected to be influenced by the microenvironmental acidity, polarity and ionic strength. Individual excipient properties contributed to the overall microenvironment in powder mixtures even when dry mixed at low water contents.
CONCLUSIONS: The environment experienced by a drug in the final solid dosage form will be influenced by the nature of the excipients, the extent of their surfaces available for interaction, surface modification during processing and the amount and nature of solvent used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933092     DOI: 10.1007/s11095-006-9085-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Effect of different acids on solid-state stability of an ester prodrug of a IIb/IIIa glycoprotein receptor antagonist.

Authors:  S I Badawy; R C Williams; D L Gilbert
Journal:  Pharm Dev Technol       Date:  1999-08       Impact factor: 3.133

2.  Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms.

Authors:  S I Badawy; R C Williams; D L Gilbert
Journal:  J Pharm Sci       Date:  1999-04       Impact factor: 3.534

3.  Evaluation of drug physical form during granulation, tabletting and storage.

Authors:  Adrian C Williams; V Brett Cooper; Lisa Thomas; Letecia J Griffith; Catherine R Petts; Steven W Booth
Journal:  Int J Pharm       Date:  2004-05-04       Impact factor: 5.875

4.  Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate.

Authors:  Sherif Badawy; Rodney Vickery; Keyur Shah; Munir Hussain
Journal:  Pharm Dev Technol       Date:  2004-08       Impact factor: 3.133

5.  The influence of measurement conditions on the Hammett acidity function of solid pharmaceutical excipients.

Authors:  Andrey V Zinchuk; Bruno C Hancock; Evgenyi Y Shalaev; Renuka D Reddy; Ramprakash Govindarajan; Elizabeth Novak
Journal:  Eur J Pharm Biopharm       Date:  2005-07-06       Impact factor: 5.571

6.  Impact of freeze-drying on ionization of sulfonephthalein probe molecules in trehalose-citrate systems.

Authors:  Ramprakash Govindarajan; Koustuv Chatterjee; Larry Gatlin; Raj Suryanarayanan; Evgenyi Y Shalaev
Journal:  J Pharm Sci       Date:  2006-07       Impact factor: 3.534

7.  Instability of digoxin in digoxin-amorphous silicon dioxide triturates prepared by solvent deposition and ball milling.

Authors:  C A Lau-Cam; C M Pendharkar; C I Jarowski; K Y Yang
Journal:  Pharmazie       Date:  1991-07       Impact factor: 1.267

8.  Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.

Authors:  B R Rohrs; T J Thamann; P Gao; D J Stelzer; M S Bergren; R S Chao
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

9.  pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets.

Authors:  A Streubel; J Siepmann; A Dashevsky; R Bodmeier
Journal:  J Control Release       Date:  2000-06-15       Impact factor: 9.776

10.  [Studies on the stability of vitamin D2 powder preparations. IV. Isomerization of vitamin D2 and related compounds catalyzed by surface acid on excipients, and active site for catalytic reactions].

Authors:  T Takahashi; R Yamamoto
Journal:  Yakugaku Zasshi       Date:  1969-07       Impact factor: 0.302

View more
  9 in total

1.  Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.

Authors:  Yi-Ling Hsieh; Jeremy M Merritt; Weili Yu; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-04-15       Impact factor: 4.200

2.  Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 2: Safety considerations of impurities in pharmaceutical products and surveying the impurity landscape.

Authors:  Karen M Alsante; Kim C Huynh-Ba; Steven W Baertschi; Robert A Reed; Margaret S Landis; Scott Furness; Bernard Olsen; Mark Mowery; Karen Russo; Robert Iser; Gregory A Stephenson; Patrick Jansen
Journal:  AAPS PharmSciTech       Date:  2013-12-21       Impact factor: 3.246

3.  The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.

Authors:  Kenneth Craig Waterman
Journal:  AAPS PharmSciTech       Date:  2011-07-12       Impact factor: 3.246

4.  Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.

Authors:  Jeremy M Merritt; Shekhar K Viswanath; Gregory A Stephenson
Journal:  Pharm Res       Date:  2012-08-24       Impact factor: 4.200

5.  Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium.

Authors:  Ramprakash Govindarajan; Margaret Landis; Bruno Hancock; Larry A Gatlin; Raj Suryanarayanan; Evgenyi Y Shalaev
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

6.  Apparent basicities of the surfaces characterizing the dominant crystal habits of distinct polymorphic forms of 4-aminosulfonamide.

Authors:  Piotr Cysewski
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

7.  Role of salt and excipient properties on disproportionation in the solid-state.

Authors:  Peter Guerrieri; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-06-09       Impact factor: 4.200

8.  Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.

Authors:  Christopher T John; Wei Xu; Lisa K Lupton; Paul A Harmon
Journal:  Pharm Res       Date:  2013-03-20       Impact factor: 4.200

9.  Impact of Magnesium Stearate Presence and Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties.

Authors:  P Zarmpi; T Flanagan; E Meehan; J Mann; Nikoletta Fotaki
Journal:  AAPS J       Date:  2020-05-21       Impact factor: 4.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.